Cargando…

Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe

BACKGROUND: Timely knowledge of which influenza vaccine brands are procured and where is of interest to inform site-selection for brand-specific influenza vaccine effectiveness (VE) studies. Vaccine procurement is a key determinant of brand availability. We therefore sought to understand how the pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stuurman, Anke L., Rizzo, Caterina, Haag, Mendel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031425/ https://www.ncbi.nlm.nih.gov/pubmed/33831021 http://dx.doi.org/10.1371/journal.pone.0248943

Ejemplares similares

Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK
por: Stuurman, Anke L., et al.
Publicado: (2021)

Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform
por: Stuurman, Anke L., et al.
Publicado: (2023)

Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years
por: McGovern, Ian, et al.
Publicado: (2023)

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
por: Boikos, Constantina, et al.
Publicado: (2022)

Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis
por: Coleman, Brenda L., et al.
Publicado: (2023)

Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons
por: Boikos, Constantina, et al.
Publicado: (2022)

Procurement Innovation for Cloud Services in Europe
por: JONES, Bob
Publicado: (2014)

902. Incidence of Influenza-Related Medical Encounters Among Adults in The United States During the 2015-2020 Influenza Seasons
por: McGovern, Ian, et al.
Publicado: (2023)

Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
por: de Lusignan, Simon, et al.
Publicado: (2020)

2640. Estimated Additional Burden Averted from Use of Cell-Based Influenza Vaccines Compared to Egg-Based Influenza Vaccines Among People 0-64 Years of Age in the United States: 2017-2020 Seasons
por: McGovern, Ian, et al.
Publicado: (2023)

Monitoring What Governments “Give for” and “Spend on” Vaccine Procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline
por: Nelson, E. A. S., et al.
Publicado: (2014)

Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
por: Dos Santos, Gael, et al.
Publicado: (2019)

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
por: Uhart, Mathieu, et al.
Publicado: (2016)

Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18–64 Years During the 2019–2020 US Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2023)

Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis
por: Coleman, Brenda L., et al.
Publicado: (2021)

PICSE (Procurement for Cloud Services Innovation in Europe) results
por: GARAVELLI, Sara
Publicado: (2016)

Procurement Innovation for Cloud Services in Europe: Initial Results
por: GARAVELLI, Sara
Publicado: (2015)

Active surveillance for safety monitoring of seasonal influenza vaccines in Italy, 2015/2016 season
por: Spila Alegiani, Stefania, et al.
Publicado: (2018)

Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59(®)‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons
por: Panatto, Donatella, et al.
Publicado: (2019)

A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines
por: Banerjee, Surojit, et al.
Publicado: (2022)

Seasonal influenza in children: Costs for the health system and society in Europe
por: Villani, Leonardo, et al.
Publicado: (2022)

Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9‐year period
por: Lunelli, Antonella, et al.
Publicado: (2012)

Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020
por: Zanobini, Patrizio, et al.
Publicado: (2022)

Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic
por: McGovern, Ian, et al.
Publicado: (2022)

Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
por: Valenciano, Marta, et al.
Publicado: (2011)

Epidemiology and Burden of Influenza in Children 0–14 Years Over Ten Consecutive Seasons in Italy
por: Barbieri, Elisa, et al.
Publicado: (2023)

Procurement of Category 2 Vaccines in China
por: Zhuang, Jian-Lin, et al.
Publicado: (2019)

European collaborations on medicine and vaccine procurement
por: Vogler, Sabine, et al.
Publicado: (2021)

Investigation of barriers to county-level seasonal influenza vaccine uptake among Medicare beneficiaries in the United States – 2018–2019 seasonal influenza season
por: Cho, Bo-Hyun, et al.
Publicado: (2023)

Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season
por: Dos Santos, Gaël, et al.
Publicado: (2021)

Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018
por: Rajaram, Sankarasubramanian, et al.
Publicado: (2020)

Influenza vaccination coverage rates in Europe – covering five consecutive seasons (2001–2006) in five countries
por: Holm, Majbrit V., et al.
Publicado: (2008)

Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season
por: Sakai-Tagawa, Yuko, et al.
Publicado: (2019)

Determinants of vaccination uptake, and influenza vaccine effectiveness in preventing deaths and hospital admissions in the elderly population; Treviso, Italy, 2014/2015-2016/2017 seasons
por: Bellino, Stefania, et al.
Publicado: (2019)

Planning for future COVID-19 vaccine procurement
por: Teerawattananon, Yot, et al.
Publicado: (2022)

Fluoride Concentration of Some Brands of Fermented Milks Available in the Market
por: Lodi, Carolina Simonetti, et al.
Publicado: (2011)

Availability of brands of six essential medicines in 124 pharmacies in Maharashtra
por: Millard, Colin, et al.
Publicado: (2018)

Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project
por: Stuurman, Anke L., et al.
Publicado: (2022)

Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
por: Böhmer, Merle M, et al.
Publicado: (2012)

Systems Biology of Seasonal Influenza Vaccination in Humans
por: Nakaya, Helder I, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nj7s1oc27uhju3bdchn77vavt7